601117.SS
China National Chemical Engineering Co., Ltd [601117.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
601117.SS Stock Summary
Top 10 Correlated ETFs
601117.SS
Top 10 Correlated Stocks
601117.SS
In the News
601117.SS Financial details
Company Rating
Strong Buy
Market Cap
38.8B
Income
5.42B
Revenue
169.52B
Book val./share
-
Cash/share
-
Dividend
0.18
Dividend %
2.79%
Employees
46.71K
Optionable
No
Shortable
Yes
Earnings
27 Oct 2023
P/E
7.22
Forward P/E
5.34
PEG
-7.58
P/S
0.23
P/B
0.7
P/C
-
P/FCF
25.77
Quick Ratio
1.13
Current Ratio
1.22
Debt / Equity
0.25
LT Debt / Equity
0.18
-
-
EPS (TTM)
0.76
EPS next Y
1.19
EPS next Q
-
EPS this Y
5.95%
EPS next Y
56.54%
EPS next 5Y
82.46%
EPS last 5Y
17.94%
Revenue last 5Y
14.23%
Revenue Q/Q
-16.97%
EPS Q/Q
-
-
-
-
-
SMA20
-5.6%
SMA50
-14.68%
SMA100
-21.22%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
10%
ROC
0.09%
Gross Margin
10%
Oper. Margin
4%
Profit Margin
3%
Payout
29%
Shs Outstand
6.11B
Shs Float
2.18B
-
-
-
-
Target Price
-
52W Range
6.34-11.3
52W High
-42.27%
52W Low
+5.83%
RSI
24.61
Rel Volume
0.93
Avg Volume
43.11M
Volume
40.26M
Perf Week
-3.64%
Perf Month
-13.72%
Perf Quarter
-21.6%
Perf Half Y
-24.04%
-
-
-
-
Beta
0.706
-
-
Volatility
0.11%, 0.19%
Prev Close
-1.4%
Price
6.35
Change
-2.61%
601117.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 16.44 | 21.09 | 21.34 | 25 | 26.04 | |
| Net income per share | 0.39 | 0.62 | 0.71 | 0.84 | 0.89 | |
| Operating cash flow per share | 0.99 | 0.96 | 1.62 | 0.41 | 0.25 | |
| Free cash flow per share | 0.79 | 0.8 | 1.45 | -0.29 | -0.25 | |
| Cash per share | 5.69 | 6.6 | 7.6 | 8.25 | 7.1 | |
| Book value per share | 6.63 | 7.12 | 7.31 | 8.74 | 8.69 | |
| Tangible book value per share | 6.66 | 7.1 | 7.44 | 8.87 | 8.96 | |
| Share holders equity per share | 6.63 | 7.12 | 7.31 | 8.74 | 8.69 | |
| Interest debt per share | 1.17 | 1.4 | 1.29 | 1.46 | 1.4 | |
| Market cap | 26.35B | 31.8B | 30.25B | 66.19B | 48.31B | |
| Enterprise value | 3.62B | 6.11B | -2.39B | 29.69B | 14.45B | |
| P/E ratio | 13.64 | 10.39 | 8.27 | 14.29 | 8.92 | |
| Price to sales ratio | 0.32 | 0.31 | 0.28 | 0.48 | 0.3 | |
| POCF ratio | 5.37 | 6.73 | 3.63 | 29.53 | 32.22 | |
| PFCF ratio | 6.72 | 8.03 | 4.06 | -41.63 | -31.33 | |
| P/B Ratio | 0.8 | 0.9 | 0.8 | 1.37 | 0.91 | |
| PTB ratio | 0.8 | 0.9 | 0.8 | 1.37 | 0.91 | |
| EV to sales | 0.04 | 0.06 | -0.02 | 0.22 | 0.09 | |
| Enterprise value over EBITDA | 0.68 | 0.91 | -0.34 | 4.08 | 1.67 | |
| EV to operating cash flow | 0.74 | 1.29 | -0.29 | 13.25 | 9.63 | |
| EV to free cash flow | 0.92 | 1.54 | -0.32 | -18.67 | -9.37 | |
| Earnings yield | 0.07 | 0.1 | 0.12 | 0.07 | 0.11 | |
| Free cash flow yield | 0.15 | 0.12 | 0.25 | -0.02 | -0.03 | |
| Debt to equity | 0.16 | 0.19 | 0.17 | 0.16 | 0.16 | |
| Debt to assets | 0.06 | 0.06 | 0.05 | 0.04 | 0.04 | |
| Net debt to EBITDA | -4.24 | -3.82 | -4.7 | -5.02 | -3.92 | |
| Current ratio | 1.39 | 1.25 | 1.21 | 1.18 | 1.19 | |
| Interest coverage | 7.35 | 19.57 | 10.35 | 24.59 | 23.85 | |
| Income quality | 2.36 | 1.44 | 2.17 | 0.45 | 0.26 | |
| Dividend Yield | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | |
| Payout ratio | 0.43 | 0.33 | 0.23 | 0.35 | 0.25 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0 | 0 | |
| Research and developement to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Capex to operating cash flow | -0.2 | -0.16 | -0.11 | -1.71 | -2.03 | |
| Capex to revenue | -0.01 | -0.01 | -0.01 | -0.03 | -0.02 | |
| Capex to depreciation | -1.01 | -0.72 | -0.77 | -3.23 | -2.22 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 7.63 | 9.96 | 10.8 | 12.85 | 13.19 | |
| ROIC | 0.05 | 0.11 | 0.09 | 0.08 | 0.09 | |
| Return on tangible assets | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Graham Net | -0.46 | -1.95 | -1.6 | -2.57 | -2.93 | |
| Working capital | 21.3B | 17.73B | 18.15B | 21.5B | 23.6B | |
| Tangible asset value | 33B | 35.05B | 38.33B | 48.93B | 54.5B | |
| Net current asset value | 14.33B | 9.51B | 10.64B | 12.66B | 14.38B | |
| Invested capital | 0.16 | 0.19 | 0.17 | 0.16 | 0.16 | |
| Average receivables | 31.41B | 35.69B | 49.71B | 72.6B | 90.18B | |
| Average payables | 28.14B | 34.22B | 45.43B | 57.86B | 66.56B | |
| Average inventory | 14.74B | 14.09B | 9.39B | 4.71B | 5.71B | |
| Days sales outstanding | 147.89 | 134.5 | 202.56 | 222.72 | 221.62 | |
| Days payables outstanding | 151.91 | 151.8 | 196.04 | 185.84 | 178.02 | |
| Days of inventory on hand | 68.94 | 57.5 | 15.72 | 15.31 | 15.79 | |
| Receivables turnover | 2.47 | 2.71 | 1.8 | 1.64 | 1.65 | |
| Payables turnover | 2.4 | 2.4 | 1.86 | 1.96 | 2.05 | |
| Inventory turnover | 5.29 | 6.35 | 23.21 | 23.83 | 23.11 | |
| ROE | 0.06 | 0.09 | 0.1 | 0.1 | 0.1 | |
| Capex per share | -0.2 | -0.15 | -0.17 | -0.69 | -0.5 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 7.44 | 6.17 | 6.93 | 7.87 | 0 | |
| Net income per share | 0.18 | 0.28 | 0.18 | 0.3 | 0 | |
| Operating cash flow per share | 0.18 | 0.28 | 0.18 | 1.01 | 0 | |
| Free cash flow per share | 0.09 | 0.08 | 0.07 | 0.91 | 0 | |
| Cash per share | 5.5 | 7.03 | 6.05 | 6.79 | 0 | |
| Book value per share | 8.35 | 8.61 | 8.76 | 8.9 | 0 | |
| Tangible book value per share | 8.38 | 8.88 | 9.02 | 9.21 | 0 | |
| Share holders equity per share | 8.35 | 8.61 | 8.76 | 8.9 | 0 | |
| Interest debt per share | 1.55 | 1.35 | 2.06 | 2.22 | 0 | |
| Market cap | 48.92B | 48.75B | 57.27B | 51.1B | 0 | |
| Enterprise value | 25.7B | 14.88B | 33.73B | 23.94B | -21.81B | |
| P/E ratio | 11.42 | 7.19 | 12.89 | 6.96 | 0 | |
| Price to sales ratio | 1.08 | 1.29 | 1.34 | 1.05 | 0 | |
| POCF ratio | 45.66 | 28.76 | 51.56 | 8.18 | 0 | |
| PFCF ratio | 91.11 | 102.26 | 130.29 | 9.09 | 0 | |
| P/B Ratio | 0.96 | 0.92 | 1.06 | 0.93 | 0 | |
| PTB ratio | 0.96 | 0.92 | 1.06 | 0.93 | 0 | |
| EV to sales | 0.57 | 0.39 | 0.79 | 0.49 | -0.54 | |
| Enterprise value over EBITDA | 16.84 | 6.21 | 21.7 | 9.29 | -20.12 | |
| EV to operating cash flow | 23.99 | 8.78 | 30.36 | 3.83 | 6.07 | |
| EV to free cash flow | 47.87 | 31.22 | 76.73 | 4.26 | 4.33 | |
| Earnings yield | 0.02 | 0.03 | 0.02 | 0.04 | 0 | |
| Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.11 | 0 | |
| Debt to equity | 0.18 | 0.16 | 0.23 | 0.25 | 0.25 | |
| Debt to assets | 0.05 | 0.04 | 0.06 | 0.06 | 0.07 | |
| Net debt to EBITDA | -15.21 | -14.12 | -15.15 | -10.55 | -20.12 | |
| Current ratio | 1.19 | 1.19 | 1.21 | 1.21 | 1.22 | |
| Interest coverage | 13.86 | 26 | 16.89 | 24.96 | 10.37 | |
| Income quality | 1 | 1 | 1 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0.02 | 0 | |
| Payout ratio | 0.19 | 0.04 | 0.07 | 0.68 | 0.27 | |
| Sales general and administrative to revenue | 0.03 | -0.03 | 0.02 | -0.01 | 0.04 | |
| Research and developement to revenue | 0.03 | 0.06 | 0.02 | 0.03 | 0.04 | |
| Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Capex to operating cash flow | -0.5 | -0.72 | -0.6 | -0.1 | 0.4 | |
| Capex to revenue | -0.01 | -0.03 | -0.02 | -0.01 | -0.04 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 5.74 | 7.32 | 5.96 | 7.72 | 0 | |
| ROIC | 0.02 | 0.03 | 0.02 | 0.03 | 0.01 | |
| Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Graham Net | -2.99 | -2.9 | -3.26 | -3.34 | 0 | |
| Working capital | 23.12B | 23.6B | 26.37B | 29.31B | 30.82B | |
| Tangible asset value | 51.15B | 54.5B | 55.65B | 56.82B | 57.55B | |
| Net current asset value | 13.41B | 14.38B | 14.89B | 16.48B | 17.69B | |
| Invested capital | 0.18 | 0.16 | 0.23 | 0.25 | 0.25 | |
| Average receivables | 96.62B | 97.34B | 100.68B | 108.73B | 114.92B | |
| Average payables | 68.13B | 70.23B | 72.19B | 79.59B | 84.23B | |
| Average inventory | 6.99B | 6.67B | 6.59B | 6.75B | 6.82B | |
| Days sales outstanding | 195.14 | 228.69 | 221.16 | 208.15 | 262.44 | |
| Days payables outstanding | 151 | 194.74 | 171.08 | 172.38 | 204.35 | |
| Days of inventory on hand | 15.25 | 17.28 | 16.02 | 13.28 | 17.33 | |
| Receivables turnover | 0.46 | 0.39 | 0.41 | 0.43 | 0.34 | |
| Payables turnover | 0.6 | 0.46 | 0.53 | 0.52 | 0.44 | |
| Inventory turnover | 5.9 | 5.21 | 5.62 | 6.78 | 5.19 | |
| ROE | 0.02 | 0.03 | 0.02 | 0.03 | 0.01 | |
| Capex per share | -0.09 | -0.2 | -0.11 | -0.1 | 0 |
601117.SS Frequently Asked Questions
What is China National Chemical Engineering Co., Ltd stock symbol ?
China National Chemical Engineering Co., Ltd is a CN stock and trading under the symbol 601117.SS
What is China National Chemical Engineering Co., Ltd stock quote today ?
China National Chemical Engineering Co., Ltd stock price is $6.35 today.
Is China National Chemical Engineering Co., Ltd stock public?
Yes, China National Chemical Engineering Co., Ltd is a publicly traded company.
Company Profile
- Volume Average 43.11M
- Market Capitalization 38.8B
- Employee 46.71K
- CEO Mr. Gang Wen
- Headquarters Beijing,CN
- IPO Date 2010-01-07
-
Website
https://cncec.com.cn 
China National Chemical Engineering Co., Ltd., an industrial engineering company, engages in the general contracting of construction, infrastructure, and overseas projects in the fields of chemical, petrochemical, pharmaceutical, power, and coal industries in China. It provides various services comprising project consulting, prospecting, design, construction, and project management environmental treatment; technology research and development and its industrialization; and installation of pipelines, circuits, and complete equipment. It is also involved in the import and export business; real estate development business; and investment and management of industrial plant and infrastructure projects. The company was founded in 1953 and is based in Beijing, China. China National Chemical Engineering Co., Ltd. is a subsidiary of China National Chemical Engineering Group Corporation Ltd.
